Caelyx
Caelyx is a medicine authorised by Swissmedic under authorisation number 54273. The authorisation holder is Baxter AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 December 1997 and the authorisation is valid without a time limit. ATC code L01DB01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 54273 |
|---|---|
| Name | Caelyx |
| Full name | Caelyx, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Baxter AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01DB01 |
| First authorisation | 24 December 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Caelyx, Konzentrat zur Herstellung einer Infusionslösung | A | 24 December 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 20 mg / 10 | ml | L01DB01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Caelyx authorised in Switzerland?
Yes. Caelyx is authorised by Swissmedic under authorisation number 54273, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Caelyx have?
Caelyx is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Caelyx?
The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.